Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
01/2002
01/31/2002WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
01/31/2002US20020013358 Indole derivatives
01/31/2002US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders
01/31/2002DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases
01/30/2002EP1175398A1 Indoline derivatives as progesterone antagonists
01/30/2002EP0707580B1 Magnesium omeprazole
01/30/2002CN1333758A Substituted bicyclic derivatives useful as anticancer agents
01/30/2002CN1333754A Benzoheterocycles and their use as MEK inhibitors
01/30/2002CN1333698A Combination chemotherapy
01/29/2002US6342502 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases
01/29/2002US6342497 2″-deoxy hygromycin derivatives
01/24/2002WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
01/24/2002US20020010206 Treating cyclooxygenase-2 mediated disorders.
01/24/2002DE10032884A1 Verfahren zur Herstellung von Propylenoxid A process for the production of propylene oxide
01/23/2002EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors
01/23/2002CN1332737A Thrombin inhibitors
01/23/2002CN1332731A Substituted benzimidazoles and their prep. and use
01/23/2002CN1332730A Process for preparing insecticide
01/22/2002US6340761 Amination and dehydrohalogenation with piperidine compounds
01/17/2002WO2002004446A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias
01/17/2002WO2002004435A1 Method for the preparation of citalopram
01/17/2002US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
01/17/2002US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
01/17/2002CA2412848A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias
01/17/2002CA2383963A1 Method for the preparation of citalopram
01/16/2002EP1171138A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions
01/16/2002CN1331691A Piperidines as CCR5 modulators
01/16/2002CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof
01/16/2002CN1331681A Synthesis of histamine dihydrochloride
01/16/2002CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors
01/16/2002CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands
01/16/2002CN1331591A Piperidines as CCR5 modulators
01/10/2002WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
01/10/2002US20020004503 Viricides
01/10/2002CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
01/10/2002CA2411864A1 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
01/09/2002EP1170293A2 Process for selective derivatization of taxanes
01/09/2002EP1170292A2 Process for selective derivatization of taxanes
01/09/2002EP1170289A2 Retroviral protease inhibiting compounds
01/09/2002EP1169314A1 Crystalline base of citalopram
01/09/2002EP1169312A2 Glucokinase activators
01/08/2002CA2294614C Omeprazole sodium salt
01/03/2002WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
01/03/2002WO2002000618A2 Progesterone receptor-regulated gene expression and methods related thereto
01/03/2002US20020002283 Process for preparing growth hormone secretagogues
01/03/2002CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators
01/02/2002EP1165553A1 C10 ester substituted taxanes as antitumor agents
01/02/2002EP1165552A1 C7 carbonate substituted taxanes as antitumor agents
01/02/2002EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents
01/02/2002EP1165550A1 C10 carbonate substituted taxanes as antitumor agents
01/02/2002EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents
01/02/2002EP1165545A1 Novel compounds
01/02/2002EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
01/02/2002EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
01/02/2002CN1329607A Substituted benzopyran analogs for treatment of inflammation
01/02/2002CN1329605A Benzofuran derivatives their preparation and use
01/02/2002CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide
01/01/2002US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment
01/01/2002US6335345 Spiro compounds
01/01/2002CA1341330C Substituted acyl dertivatives of 1,2,3,4-tetrahydroisquinoline-3-carboxylic acids
12/2001
12/27/2001WO2001098303A1 Novel process for the preparation of pyrazolopyrimidinones
12/27/2001WO2001098273A1 Novel compounds
12/26/2001CN1328554A Eletriptan hydrobromide monohydrate
12/26/2001CN1327982A Process for preparing 2-chloro-thiazole compound
12/26/2001CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/25/2001CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation
12/20/2001WO2001096338A1 Non-nucleoside reverse transcriptase inhibitors
12/20/2001WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
12/19/2001EP1164132A2 Crystalline magnesium omeprazole
12/18/2001CA2085589C Benzoquinazoline compounds
12/13/2001WO2001094341A1 Quinazoline derivatives for the treatment of tumours
12/13/2001US20010051640 C7 carbamoyloxy substituted taxanes
12/12/2001EP0861248B1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
12/12/2001CN1326451A Improved phlegmatization of cyclic ketone peroxides
12/12/2001CN1076019C Preparation of triazoles by organometallic addition to ketonts and intermediates therefor
12/11/2001US6329522 Glycosylating purine or pyrimidine base or analogue thereof with oxathiolan or dithiolan derivative in presence of lewis acid catalyst
12/11/2001US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001US6328855 Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes
12/06/2001WO2001092263A1 Novel triazolo pyrimidine compounds
12/06/2001WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis
12/06/2001WO2001091756A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
12/06/2001CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
12/06/2001CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/05/2001EP1160243A1 Process for producing quinazoline derivative or salt thereof
12/05/2001EP1159272A1 A process for the preparation of 1,4,7,10-tetraazacyclododecane
12/05/2001EP0994872B9 4-phenylpiperidine compounds
12/05/2001EP0956284A4 Process for selective derivatization of taxanes
12/05/2001EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
12/04/2001US6326375 Containing an urea group
11/2001
11/29/2001WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001US20010047105 EP4 receptor selective agonists in the treatment of osteoporosis
11/29/2001US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/28/2001EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001EP0712394B1 Arthropodicidal oxazolines and thiazolines
11/28/2001CN1324351A Method for the preparation of citalopram
11/28/2001CN1324348A TAN-1057 derivatives
11/28/2001CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 105